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Abstract 26 
Tissue hypoxia has been proposed as an important event in renal ischemia 27 
reperfusion injury (IRI), particularly during the period of ischemia and in the immediate hours 28 
following reperfusion. However, little is known about renal oxygenation during the subacute 29 
phase of IRI. We employed four different methods to assess the temporal and spatial changes 30 
in tissue oxygenation during the subacute phase (24 h and 5 days after reperfusion) of a severe 31 
form of renal IRI in rats. We hypothesized that the kidney is hypoxic 24 h and 5 days after an 32 
hour of bilateral renal ischemia, driven by a disturbed balance between renal oxygen delivery 33 
(DO2) and oxygen consumption (VO2). Renal DO2 was not significantly reduced in the 34 
subacute phase of IRI. In contrast, renal VO2 was 55% less 24 h, and 49% less 5 days after 35 
reperfusion than after sham-ischemia. Inner medullary tissue PO2, measured by 36 
radiotelemetry was 25 ± 12% greater 24 h after ischemia than after sham-ischemia. By 5 days 37 
after reperfusion, tissue PO2 was similar to that in rats subjected to sham-ischemia. Tissue 38 
PO2 measured by Clark electrode was consistently greater 24 h, but not 5 days, after ischemia 39 
than after sham-ischemia. Cellular hypoxia, assessed by pimonidazole adduct 40 
immunohistochemistry, was largely absent at both time-points and tissue levels of hypoxia 41 
inducible factors were downregulated following renal ischemia. Thus, in this model of severe 42 
IRI, tissue hypoxia does not appear to be an obligatory event during the subacute phase, likely 43 
due to the markedly reduced oxygen consumption. 44 
 45 
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Introduction 48 
Acute kidney injury (AKI) is a major cause of death and disability globally and 49 
places a major acute burden on healthcare systems (26). It also renders patients more 50 
susceptible to later development of chronic kidney disease (CKD) (2). For example, a 51 
diagnosis of AKI was found to be associated with an 8.8 fold excess risk of later development 52 
of CKD (8). Furthermore, the risk of later development of CKD increases with the severity of 53 
AKI (8). Tissue hypoxia has been proposed as an important driver in the pathogenesis of both 54 
AKI and CKD, although this proposition remains to be definitively tested (33).   55 
Ischemia reperfusion injury (IRI) sustained from medical interventions often arises 56 
from the obligatory need to restrict or completely prevent blood flow to the kidney, resulting 57 
in a period of severe hypoxia or complete anoxia (15). Cellular damage such as acute tubular 58 
necrosis and tubular apoptosis is evident during the reperfusion period and is likely driven in 59 
part by the presence of tissue hypoxia during the period of ischemia. In experimental IRI, 60 
cortical (27, 28, 41) and medullary (27, 28, 34) tissue hypoxia has also been observed during 61 
the first few hours of reperfusion after complete renal ischemia. Importantly, the kidney was 62 
observed to be hypoxic even with some level of, albeit incomplete, structural and functional 63 
recovery (3, 4). However, there are little available data regarding renal tissue oxygenation 64 
beyond the first few hours of reperfusion during the extension and recovery phase of IRI. This 65 
information is required if we are to understand the role of tissue hypoxia in the natural history 66 
of AKI, either as it progresses to end-stage renal disease or renal function recovers but the 67 
risk of later CKD is increased.    68 
The chief aim of the current study was to assess the time-course of changes in, and 69 
the spatial distribution of, tissue oxygen tension (PO2) during the subacute phase of severe IRI 70 
(the first 5 days of reperfusion after 60 min of bilateral renal ischemia). We chose severe IRI 71 
in an attempt to model the clinical situation of severe AKI leading to end-stage renal disease, 72 
4 
 
cognizant of the possibility that renal oxygenation in this scenario might differ considerably 73 
from that in milder forms of renal IRI. We tested the hypothesis that renal tissue is hypoxic 74 
during the subacute phase of IRI. Four approaches were used for assessment of renal tissue 75 
oxygenation, each with varying temporal and spatial resolution. Radiotelemetry was used to 76 
examine the time-course of changes in inner medullary tissue PO2 in freely-moving rats (22, 77 
23). Clark-type electrodes were used to characterize the spatial variations in renal tissue PO2 78 
in the renal cortex and medulla of anesthetized rats at both 24 h and 5 days after reperfusion. 79 
This experiment also provided an opportunity to determine the contribution of changes in 80 
renal oxygen delivery (DO2) and oxygen consumption (VO2) to alterations in renal tissue PO2 81 
24 h and 5 days after reperfusion. Pimonidazole adduct immunohistochemistry was used to 82 
characterize the spatial distribution of cellular hypoxia 24 h and 5 days after reperfusion. We 83 
also measured the expression of hypoxia-inducible factors (HIF-1α and HIF-2α) and some of 84 
their downstream gene targets.  85 
 86 
Methods 87 
Experimental Animals  88 
Ten to twelve week old male, Sprague-Dawley rats (n=70) were obtained from the 89 
Animal Resources Centre (Perth, Western Australia). They were housed in a room maintained 90 
at 21–23 ºC with a 12 h light/dark cycle.  The rats were allowed free access to water and 91 
standard laboratory rat chow. All procedures were approved in advance by the Animal Ethics 92 
Committee of the School of Biomedical Sciences, Monash University as being in accordance 93 
with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.  94 
 95 
Induction of bilateral renal ischemia 96 
Rats were anesthetized with isoflurane (IsoFlo™, 05260-05, Abbott Laboratories, 97 
USA), using a vaporizer and maintained at 2.5 – 3.0% v/v. A midline incision was made to 98 
5 
 
expose the left and right renal arteries. To induce bilateral renal ischemia (n = 36), blood flow 99 
to both kidneys was prevented by the application of microvascular clamps (00398, S&T AG, 100 
Switzerland) placed on both the left and right renal arteries and veins. Complete ischemia was 101 
confirmed by observing the blanching of the kidneys. After an hour, the microvascular clamps 102 
were removed, so blood flow to both kidneys was restored. Wounds were closed in layers 103 
with sutures and each rat was then allowed to recover from the surgery on a heated pad for an 104 
hour. A separate cohort of rats (n = 34) underwent the same procedure with the exception of 105 
the application of the microvascular clamps and so served as controls (sham-ischemia). Rats 106 
received subcutaneous injections of an analgesic (carprofen, 1.25 mg, Pfizer, Australia) for 107 
two consecutive days following recovery from surgery. 108 
  109 
Protocol 1: Temporal changes in renal tissue oxygenation following renal ischemia 110 
We employed a radiotelemetric method (22, 23) to characterize the temporal profile 111 
of changes in renal tissue PO2 after renal ischemia and reperfusion. Briefly, the oxygen 112 
telemeter was implanted under isoflurane anesthesia so that the tip of the oxygen-sensing 113 
carbon paste electrode was in the inner medulla of the left kidney (5 mm below the renal 114 
capsule). One week after implantation of the telemetric probe, the rats underwent a second 115 
surgical procedure for the induction of either bilateral renal ischemia (n = 7, body weight = 116 
501 ± 20 g) or sham-ischemia (n = 5, body weight = 491 ± 21 g). Renal tissue PO2 was 117 
recorded continuously for 1 day before and for 5 days after recovery from surgery. Rats 118 
received subcutaneous injections of an analgesic (carprofen, 1.25 mg, Pfizer, Australia) prior 119 
to laparotomy and for two consecutive days following recovery from surgery. 120 
Measurements & Calculations: Current measured by the telemeters was filtered with a 25 Hz 121 
low-pass filter and artifactual measurements were removed when the 1
st
 order derivative of 122 
the measured current exceeded the threshold of 5-500 nA/s. The zero-offset current, acquired 123 
when the rat was killed at the end of the study via induction of cardiac arrest under anesthesia 124 
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(22), was determined and subtracted. Data are presented as a percentage of the average value 125 
on the day before surgery to induce ischemia or sham-ischemia.  126 
 127 
Protocol 2: Renal tissue oxygenation and its determinants after renal ischemia  128 
Either 24 h or 5 days following recovery from renal ischemia or sham-ischemia, rats 129 
were anesthetized and prepared for the assessment of regional tissue PO2 using a Clark 130 
electrode (50 μm tip, OX-50, Unisense, Denmark). We assessed i) cortical tissue PO2 across a 131 
range of sites on the dorsal surface of the kidney and ii) a profile of tissue PO2 with depth 132 
from the cortical surface. In this set of studies, we also determined the major determinants of 133 
tissue PO2, renal DO2 and VO2. 134 
Rats (n = 6-11 per group) were anesthetized with sodium thiobutabarbital (100 135 
mg/kg i.p., Inactin; Sigma, St Louis, MO, USA). A tracheostomy was performed to facilitate 136 
artificial ventilation with 40% inspired oxygen at a ventilation rate of 90–100 breaths/min and 137 
a tidal volume of 3.5 ml (Ugo Basile, Model 7025, SDR Clinical Technology, NSW, 138 
Australia) as previously described (1). The left carotid artery was catheterized to facilitate 139 
arterial blood sampling and blood pressure measurement. The right jugular vein was 140 
catheterized to facilitate infusion of maintenance fluid (154 mM NaCl) at a rate of 6 ml/h 141 
during the period of surgical preparation. The bladder was catheterized, for collection of urine 142 
from the left kidney, for assessment of renal function using standard clearance methods. The 143 
degree of saturation of hemoglobin with oxygen was measured continuously using a sensor 144 
placed on the foot (Mouse Ox, Starr Life Sciences, Oakmont, PA, USA).  145 
The right renal artery and vein were ligated and a catheter was passed from the right 146 
renal vein through the vena cava and into the left renal vein for the sampling of renal venous 147 
blood. Total renal blood flow (RBF) was measured using a transit-time ultrasound flow probe 148 
(Type 0.7 VB, Transonic Systems Inc., NY, USA) placed around the left renal artery. 149 
Following completion of the surgical preparations, rats received bolus doses of [
3
H]-inulin 150 
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(10 μCi in 50 μl, Perkin Elmer Australia, Melbourne, Australia) and pancuronium bromide (2 151 
mg/kg, Astra Zeneca Pty Ltd, NSW, Australia) intravenously. A maintenance infusion of 2% 152 
w/v bovine serum albumin (Sigma Aldrich, St Loius, MO, USA) in 154 mM sodium chloride 153 
delivered 676 nCi/h [
3
H] inulin and 0.1 mg/kg/h pancuronium bromide through the jugular 154 
vein at a rate of 2 ml/h. The infusion commenced once all surgical preparations were 155 
completed and was maintained throughout the rest of the protocol. 156 
After a 1 h equilibration period, a 0.5 ml sample of arterial blood was taken for blood 157 
oximetry. The plasma component of the sample was later used for assessment of the 158 
concentrations of [
3
H]-inulin and sodium. A 0.1 ml sample of renal venous blood was also 159 
collected for blood oximetry. Renal tissue PO2 was then assessed using a Clark electrode 160 
attached to a micromanipulator. Two series of measurements were taken. In the first series, 161 
the electrode was advanced 2 mm from the renal surface, into the cortex, at 6 randomly 162 
chosen sites across the left kidney. The second series established a profile of tissue PO2 with 163 
depth below the cortical surface. The electrode was moved to the mid-point of the cortical 164 
surface of the kidney and advanced into the kidney at 1 mm increments up to a depth of 10 165 
mm from the renal surface as previously described (32). Once all measurements were taken, a 166 
second set of blood samples, from the carotid artery and the renal vein, was taken as before. 167 
Urine made by the left kidney, during the period of measurement of tissue PO2, was collected 168 
for measurement of the concentrations of [
3
H]-inulin and sodium. 169 
 170 
Measurements & Calculations: Arterial pressure, heart rate (triggered by arterial pressure), 171 
RBF, core body and tissue temperature and renal tissue PO2 measured by Clark electrode 172 
were digitized as previously described (32). Urinary and plasma concentrations of sodium 173 
were determined using ion-sensitive electrodes (EasyElectrolytes, Medica Corporation, 174 
Bedford USA). Glomerular filtration rate (GFR) was determined by the clearance of [
3
H]-175 
inulin. Blood chemistry was assessed using a point-of-care device (iSTAT®, CG8+ 176 
8 
 
cartridges, Abbott laboratories, Abbott Park, IL, USA). Arterial and venous blood oxygen 177 
content was calculated as previously described (1).  178 
 179 
Protocol 3: Cellular hypoxia and hypoxic signaling after renal ischemia 180 
Either after 24 h or 5 days of recovery from bilateral renal ischemia or sham -181 
ischemia (n = 6 per group), rats were prepared for perfusion-fixation of the right kidney. In 182 
this set of studies, the chief aim was to assess cellular hypoxia using pimonidazole adduct 183 
immunohistochemistry. Pimonidazole chloride (HP1-1000Kit, Hydroxyprobe Inc., USA) was 184 
administered, at a dose of 60 mg/kg i.p. three hours before perfusion-fixation of the kidney. 185 
Three hours after the injection of pimonidazole, rats were anesthetized with sodium 186 
pentobarbital (60 mg/kg, i.p., Sigma Aldrich, MO, USA). The left carotid artery was 187 
catheterized to facilitate arterial blood sampling. A midline incision was then made exposing 188 
both kidneys and the bladder. A urine sample was taken by puncturing the bladder wall and 189 
was frozen at -20 °C for later analysis. The left renal artery and vein were isolated and freed 190 
from surrounding connective tissue and fat. Lidocaine (2% w/v; Xylocaine®, Astra Zeneca, 191 
NSW, Australia) was applied onto both vessels to prevent spasm of the renal artery. Silk 192 
ligatures (3/0 Dysilk, Dynek Pty Ltd, SA, Australia) were placed around the vena cava above 193 
the level of the right kidney, around the left renal artery and vein and around the abdominal 194 
aorta. An incision was made in the abdominal aorta below the level of the left kidney and a 195 
polyurethane catheter connected to the perfusion apparatus was advanced into the aorta, 196 
facing upstream, thereby facilitating retrograde perfusion. A 1 ml blood sample was taken 197 
from the carotid artery for later analysis. The left renal artery and vein were then ligated and 198 
the left kidney removed, decapsulated and snap frozen in liquid nitrogen for later analysis of 199 
HIF-1α and HIF-2α protein and gene expression of HIF-1α, HIF-2α, VEGF-α and HO-1. 200 
Prior to freezing, the left kidney was sectioned in the coronal plane into 4-5 slices of 201 
approximately 1–2 mm thickness.  202 
9 
 
The ligatures surrounding the vena cava and abdominal aorta were tied off and the 203 
right kidney perfused with 100–150 ml of 4% w/v paraformaldehyde (PFA, 204 
paraformaldehyde powder, no. 158127, Sigma-Aldrich) at room temperature and a pressure of 205 
150 mmHg. The inferior vena cava was incised to vent perfusate. The perfused kidney was 206 
removed, decapsulated and stored in 4% PFA for 48 h before it was processed for embedding 207 
and staining at the Monash Histology Platform.   208 
Blood chemistry was assessed using a point-of-care device (iSTAT®, CHEM8+ 209 
cartridges, Abbott laboratories). Urinary albumin concentration was determined using direct 210 
competitive enzyme linked immunosorbent assay (Nephrat II, NR 002, Exocell Inc., PA, 211 
USA). Urinary creatinine concentration was determined using an assay based on Jaffe’s 212 
reaction of alkaline picrate solution with creatinine (Creatinine Companion, 1012 Strip Plate, 213 
Exocell Inc.). 214 
 215 
Quantification of fibrosis. The right kidney was processed, embedded in paraffin and 216 
sectioned at a thickness of 5 μm in the coronal plane. Collagen deposition was assessed by 217 
staining with 1% w/v picrosirius red. The cortical, outer and inner medullary region of the 218 
kidney in each section was identified using Aperio Imagescope (Leica Biosystems Imaging 219 
Inc., Australia). The amount of collagen deposited was quantified as a percentage of the entire 220 
area in each region.      221 
 222 
Pimonidazole adduct immunohistochemistry. Antigen retrieval was carried out by incubating 223 
the sections in citrate buffer (Target Retrieval Solution, DAKO, Australia) at 90 °C for 30 224 
min. Sections were then washed in tris-buffered saline (154 mM NaCl) with Tween 20 225 
(DAKO Australia) (TBST) once they had cooled to 80 °C. Excessive tissue peroxidase 226 
activity was then quenched using 0.03% v/v hydrogen peroxide containing sodium azide 227 
(DAKO, Denmark) for 10 min. Sections were then incubated in a protein block serum 228 
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(Protein Block Serum-free, DAKO, Australia) for 10 min, in order to remove non-specific 229 
binding, and washed twice more in TBST. Sections were then treated with an affinity purified 230 
polyclonal anti-pimonidazole antibody raised in the rabbit (1:200 dilution, PAb2627AP, 231 
Hydroxyprobe Inc.) for 1 h at room temperature before incubation in goat anti-rabbit 232 
secondary antibody conjugated with horseradish peroxidase (polyclonal goat EnVision, 233 
DAKO, Denmark) for 30 min at room temperature. Sections were washed twice with TBST 234 
before incubation with 3-diaminobenzidine (DAKO, Denmark) for 10 min and then 235 
counterstained with haematoxylin (DAKO, Automations Hematoxylin, USA) before being 236 
cover-slipped. 237 
 238 
Western blot analysis of HIF-1α and HIF-2α proteins. The snap frozen kidney was thawed 239 
and the cortex, outer and inner medulla inclusive of the papilla were rapidly dissected. To 240 
stop further enzymatic reactions, the tissue samples were placed in 8 μl per mg of 241 
radioimmuno-precipitation assay (RIPA) buffer (consisting of 50 mM Tris-Hcl, 150 mM 242 
NaCl, 0.1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecylsulphate (SDS), 243 
1 mM sodium orthovanadate, 1 mM NaF, 1:25 of 25x phosphatase inhibitor, 1:10 of 10x 244 
phosphostop and 1:1000 dithiothreitol). The tissues were then homogenized at 14,000 RPM at 245 
4 °C for 20 min and equal amounts of protein (30 µg, determined by a Bradford protein assay) 246 
were loaded into a 7.5% pre-cast gel (7.5% Mini-Protean® TGX™ Precast Protein Gels, 247 
4561025, Bio-Rad Laboratories, USA) and fractionated electrophoretically in 248 
Tris/Glycine/SDS running buffer at 300 V for 20 min. The fractionated protein in the gel was 249 
then transferred onto a nitrocellulose membrane (Bio-Rad Laboratories). Non-specific binding 250 
was blocked with 5% skim milk in TBST buffer. As the primary antibodies for HIF-1α 251 
(NB100-479, Novus Biologicals, LLC, CO, USA) and HIF-2α (NB100-122, Novus 252 
Biological LLC) are similar in molecular weight (115 and 118 kDa), we carried out the 253 
immunoblot analysis of each protein of interest on separate gels. The nitrocellulose 254 
11 
 
membranes were incubated overnight at 4 °C in the primary antibody (1:1000, raised in 255 
rabbit) made up in a solution of 2.5% w/v bovine serum albumin. The membranes were then 256 
incubated with 1:4000 secondary antibody (ECL™ anti-rabbit IgG, HRP-linked whole 257 
antibody, GE Healthcare UK Limited, UK) and 1:15,000 conjugate (Precision Protein™ 258 
StrepTactin-HRP conjugate, Bio-Rad Laboratories) for an hour at room temperature. The 259 
nitrocellulose membrane was developed using equal parts of Clarity™ Western Peroxide 260 
Reagent (Bio-Rad Laboratories) and Clarity™ Western Luminol/Enhancer Reagent (Bio-Rad 261 
Laboratories) for 3 min before imaging. The intensity of the bands observed on the membrane 262 
was quantified and corrected for variability in protein migration down the gel and for total 263 
protein content loaded into the wells. Comparisons were made between treatment groups 264 
across the two time points within each region (i.e. cortex, outer and inner medulla).  265 
 266 
Quantitative real-time PCR. The tissue samples were homogenized and total RNA was 267 
isolated using the RNeasy Mini Kit (74104, Qiagen Inc., Australia). Pre-designed assays for 268 
primers of the 18s house keeping gene (Rn03928990_g1), HIF-1α (Rn01472831_m1), HIF-269 
2α (Rn00576515_m1), VEGF-α (Rn01511602_m1) and HO-1 (Rn00561387_m1) genes were 270 
obtained from ThermoFisher Scientific Inc. Real-time PCR was performed on ABI 7900 HT 271 
(ThermoFisher Scientific Inc., Australia). Data were calculated by the 2
-ΔΔCt
 method. 272 
 273 
Statistical analysis 274 
Statistical analyses were performed using the software package SYSTAT (Version 275 
13, Systat Software, San Jose, CA). Two-sided P ≤ 0.05 was considered statistically 276 
significant. Normality was assessed using the Shapiro-Wilk test (40). Data that did not violate 277 
normality are presented as mean ± standard error of the mean (SEM) while data that violated 278 
normality are presented as median (25th percentile, 75th percentile). Analysis of variance 279 
(ANOVA) was used to assess the independent effects of treatment and time and their 280 
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interaction. For data the violated normality, an ANOVA on ranking (9) was performed 281 
instead. Dichotomous comparisons of continuous variables were made using Student’s t-test 282 
for data that did not violate normality and the Mann-Whitney U-test was performed for data 283 
that violated normality. To protect against the risk of type I error arising from multiple 284 
comparisons, P-values were conservatively adjusted using the Dunn-Sidak procedure (30). P-285 
values derived from within-subjects factors in repeated measures ANOVA were 286 
conservatively adjusted using the method of Greenhouse and Geisser (31).   287 
Results 288 
Protocol 1: Temporal changes in renal tissue oxygenation following renal ischemia 289 
On the first day after reperfusion, inner medullary tissue PO2 measured by telemetry 290 
was 25 ± 12% greater than its control level (Day -1) (Fig. 1). Tissue PO2 then gradually fell to 291 
be close to its control level by the fifth day after reperfusion of the kidney. After sham-292 
ischemia, inner medullary tissue PO2 tended to gradually fall, so was 22 ± 11% less than its 293 
control level by day five after surgery.  294 
 295 
Protocol 2: Renal tissue oxygenation and its determinants after renal ischemia  296 
Systemic parameters. Twenty-four hours after reperfusion, body weight did not differ 297 
significantly from that of rats that underwent sham-ischemia. By 5 days after renal ischemia, 298 
rats had lost 39.2 ± 6.1 g of their body weight. Left kidney weight 24 h after renal ischemia 299 
was similar to that after sham-ischemia. In contrast, left kidney weight was 56% greater 5 300 
days following renal ischemia than after sham-ischemia (Table 1). Mean arterial pressure was 301 
similar in the two groups of rats at both 24 h and 5 days after surgery.  302 
Renal tissue oxygenation. Tissue PO2 in the renal cortex was highly heterogenous, both 24 h 303 
and 5 days after either ischemia or sham-ischemia (Fig. 2A). Cortical PO2 was, on average, 304 
40% greater 24 h following renal ischemia than after sham-ischemia. By five days after renal 305 
ischemia, cortical tissue PO2 was 39% less than 24 h after ischemia and similar to that in rats 306 
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subjected to sham-ischemia five days previously (Fig. 2B). Tissue PO2 varied little with depth 307 
from the cortical surface. At 24 h after reperfusion, tissue PO2 tended to be greater in rats 308 
subjected to ischemia than those subjected to sham-ischemia, the difference reaching 309 
statistical significance at depths of 5 mm (inner medulla), and 9 and 10 mm (cortex) (Fig. 310 
2C). Five days after renal ischemia tissue PO2 did not differ significantly from its level in rats 311 
subjected to sham-ischemia, at any depth below the cortical surface (Fig. 2D).   312 
Renal hemodynamics and function. Renal blood flow was not significantly different in rats 313 
subjected to ischemia, compared with rats subjected to sham-ischemia, both 24 h and 5 days 314 
after surgery (Table 2). Twenty-four hours after ischemia, mean GFR (-99%), urine flow (-315 
82%) and sodium excretion (-85%) were less than in after sham-ischemia (Table 2). 316 
Fractional excretion of sodium did not differ significantly 24 h after ischemia compared to 317 
sham-ischemia. By five days after ischemia, renal function was highly variable between rats, 318 
with some rats having recovered relatively normal GFR while others remained in apparent 319 
renal failure. Consequently, none of these variables differed significantly from their level in 320 
rats subjected to sham-ischemia. We were unable to detect a significant correlation (r
2
 = 0.03, 321 
n=8), in rats subjected to ischemia, between GFR and tissue PO2 at day 5 after surgery. 322 
Blood oximetry and renal oxygen consumption and delivery. Arterial blood hematocrit 24 h 323 
after renal ischemia was 12% less than after sham-ischemia (Table 1). We were unable to 324 
detect a significant correlation (r
2
=0.034, n=9), in rats subjected to ischemia, between 325 
hematocrit and tissue PO2 24 h after reperfusion. By 5 days after renal ischemia, hematocrit 326 
was similar in the two groups of rats.  Arterial blood PO2 was 22% less, and SO2 2.7% less, in 327 
rats 24 h after renal ischemia than after sham surgery. Renal DO2 tended to be (29%) less 24 h 328 
after renal ischemia than sham-ischemia, although this apparent effect was not statistically 329 
significant (P = 0.06). There was no significant difference in renal DO2 5 days after surgery. 330 
When both time points were considered together (24 h and 5 days), renal VO2 was 55% less 331 
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in rats subjected to ischemia than in those subjected to sham surgery. The fractional extraction 332 
of oxygen did not differ significantly between the treatments at either time-point. 333 
 334 
Protocol 3: Cellular hypoxia and hypoxic signaling after renal ischemia 335 
Pimonidazole adduct immunohistochemistry. No pimonidazole adducts were detected in 336 
tissues from rats that did not receive pimonidazole chloride or in sections that were not 337 
incubated with the primary antibody (data not shown). Kidney sections from sham operated 338 
rats appeared morphologically normal (Fig. 3 & 4). Pimonidazole adducts were largely absent 339 
in the cortical region of rats 24 h following sham-ischemia. However, there was diffuse 340 
staining of pimonidazole adducts in tubular elements of the outer and inner medulla following 341 
sham-ischemia. Kidney sections from rats 24 h following recovery from renal ischemia 342 
showed relatively little staining for pimonidazole adducts across all regions of the kidney, but 343 
some diffuse staining was present 5 days following ischemia and reperfusion. However, 344 
luminal aspects of tubules were often stained positive for pimonidazole adducts after renal 345 
ischemia, suggestive of marked tubular obstruction. There was significant cellular sloughing 346 
and disintegration of the brush border/apical membrane of tubules after renal ischemia. In 347 
addition, there were considerable cellular debris in the luminal aspects of tubules at 24 h after 348 
renal ischemia. Tubular profiles surrounding the debris-riddled tubules were often flattened. 349 
In contrast, tubules appeared to be mostly dilated 5 days after renal ischemia. By 5 days after 350 
ischemia, tubules in the cortex, outer and inner medulla appeared to be more dilated than after 351 
sham-ischemia or 24 h after renal ischemia.  352 
HIF-1α and HIF-2α proteins. When both the 24 h and 5 day time-points were considered 353 
collectively, the expression of HIF-1α protein in the cortex, outer medulla and inner medulla 354 
was less after renal ischemia than after sham-ischemia (Fig. 5A-C). However, not all 355 
comparisons at individual time-points were statistically significant.  HIF-1α levels in the 356 
cortex were 88.3% less 5 days after renal ischemia than at the corresponding time-point after 357 
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sham-ischemia (Fig. 5A). Similarly, in the outer medulla, HIF-1α was 62.2% less 24 h after 358 
renal ischemia and 79.7% less 5 days after renal ischemia than after sham surgery (Fig. 5B). 359 
In contrast, in the inner medulla, levels of HIF-1α protein did not differ significantly, between 360 
rats subjected to ischemia compared to those subjected to sham-ischemia, at either the 24 h or 361 
5 day time-point (Fig. 5C). When both the 24 h and 5 day time points were considered 362 
collectively, the expression of HIF-2α protein was markedly less, in rats subjected to ischemia 363 
compared to those subjected to sham-ischemia, in the cortex and the outer medulla but not in 364 
the inner medulla. The level of HIF-2α in the cortex was 86.9% less 5 days after ischemia 365 
than after sham-ischemia (Fig. 5D). In the outer medulla of rats subjected to renal ischemia, 366 
HIF-2α expression was 55% less 24 h and 89.2% less 5 days after ischemia, than after sham-367 
ischemia (Fig. 5E). The deficits in HIF-1α and HIF-2α in rats subjected to renal ischemia did 368 
not diminish between the 24 h and 5 day time points, if anything, becoming more marked 369 
(Fig. 5).  370 
Expression of genes for HIF-1α, HIF-2α, VEGF-α and HO-1. There were no significant 371 
differences in the expression of mRNA for HIF-1α, HIF-2α or VEGF-α, either 24 h or 5 days 372 
following renal ischemia compared to after sham-ischemia (Fig. 6). The expression of HO-1 373 
tended to be greater after ischemia than after sham-ischemia, although this apparent effect 374 
was only statistically significant at the 5 day time-point. 375 
Collagen deposition. Twenty-four hours after renal ischemia, picrosirius red staining did not 376 
differ significantly, from that seen in rats subjected to sham-ischemia, in either the cortex or 377 
the outer medulla. However, it was 43% less in the inner medulla (Fig. 7). By 5 days after 378 
renal ischemia, picrosirius red staining was 50% greater in the cortex of rats subjected to 379 
ischemia than those subjected to sham-ischemia. There was an apparent effect of the duration 380 
of recovery period on picrosirius red staining, which in the cortex and inner medulla was 381 
significantly greater 5 days after ischemia or sham-ischemia than at the 24 h time point.  382 
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Indices of renal dysfunction. The plasma concentrations of urea and creatinine, and the 383 
urinary albumin-creatinine ratio were all greater in rats after ischemia than after sham-384 
ischemia (Fig. 8). These effects were statistically significant at the individual time points with 385 
the exception of urinary albumin to creatinine ratio 24 h after ischemia, where sufficient urine 386 
for analysis could only be generated from two animals.   387 
Discussion 388 
We determined the time-course of changes in, and the spatial distribution of, renal 389 
tissue PO2 during the subacute phase of severe renal IRI. Using four different methods for 390 
assessing renal tissue oxygenation, we could not detect tissue hypoxia during the 391 
extension/recovery phase of IRI. Indeed, if anything, there was relative hyperoxia up to 48 h 392 
after an hour of bilateral renal ischemia. We also observed downregulation of the abundance 393 
of HIF-1α and HIF-2α protein, particularly in the cortex and outer medulla, both 24 h and 5 394 
days after reperfusion. The apparent absence of renal hypoxia is consistent with the pattern of 395 
changes in renal DO2 and VO2 after ischemia and reperfusion. That is, RBF was relatively 396 
normal but there was a marked reduction in sodium reabsorption, and so presumably oxygen 397 
utilization for sodium reabsorption, at both 24 h and 5 days after reperfusion. When both 398 
time-points were considered together, renal VO2 was significantly less, and DO2 tended to be 399 
less, in rats subjected to ischemia than in those subjected to sham-ischemia. Thus, tissue PO2 400 
appears to be well maintained during the extension/recovery phase of severe renal IRI 401 
because changes in renal DO2 and VO2 are relatively balanced. 402 
The methods we used to assess renal oxygenation have both strengths and 403 
weaknesses (11, 33). Radiotelemetry allows continuous measurement of renal tissue PO2 in 404 
the absence of confounding effects of anesthesia (22, 23). However, tissue PO2 can only be 405 
expressed in relative terms and can be measured at only one site in each animal. Clark 406 
electrodes allow generation of a spatial map of tissue PO2, but only in anesthetized animals 407 
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(11, 33). Furthermore, it is not possible to resolve tissue PO2 to the level of specific vascular 408 
and tubular elements, except in the superficial cortex (43). In addition, as we have found 409 
previously with Clark electrodes inserted into renal tissue from the dorsal surface of the 410 
kidney (32), the steep cortico-medullary gradient in tissue PO2 generated in many previous 411 
studies (6, 10, 29) is not obviously evident. We have no adequate explanation for this, 412 
although it may relate to our use of relatively large electrodes (50 μm) or the angle of entry to 413 
the renal tissue, from the dorsal surface of the kidney, as a consequence of which the tip of the 414 
electrode does not enter the renal papilla. Pimonidazole adduct immunohistochemistry allows 415 
detection of cells with PO2 < 10 mmHg but does not provide a quantitative measure of tissue 416 
PO2 (37). Furthermore, as we found in the current study and previously (1), it is prone to 417 
artifactual staining of cellular debris and casts within damaged tubules. Quantification of the 418 
abundance of HIF-1α and HIF-2α protein provides information about the state of hypoxia 419 
signaling pathways. However, factors other than tissue PO2 contribute to the regulation of 420 
HIF signaling (16). Thus, interpretation of our failure to detect hypoxia by any one of these 421 
methods would merit caution. However, the fact that our observations were consistent across 422 
the four methods provides compelling evidence that, at least in this severe form of IRI, tissue 423 
hypoxia is not an obligatory characteristic of the period from 24 h to 5 days after severe renal 424 
ischemia and reperfusion.  425 
The most likely explanation for the absence of hypoxia 24 h and 5 days after 426 
reperfusion, and even increased tissue PO2 at 24 h, is reduced sodium reabsorption and thus 427 
renal VO2. In the rats we studied, the deficit in sodium reabsorption 24 h after ischemia and 428 
reperfusion could be attributed to the decreased filtered load of sodium. This appears to drive 429 
downregulation of Na
+
-K
+
-ATPase activity. For example, in response to severe renal 430 
ischemia (i.e. 60 min), the abundance (and activity) of basolateral Na
+
-K
+
-ATPase pumps, the 431 
apical Na-K-2Cl and the thiazide-sensitive Na
+
-Cl
-
 cotransporters was shown to be greatly 432 
18 
 
reduced (25). But the magnitude of the apparent reduction in renal VO2 we observed was 433 
considerably less than the magnitude of the reduction in sodium reabsorption. For example, 434 
sodium reabsorption was less than 1% of rats subjected to sham-ischemia, while VO2 was 435 
34% that of rats subjected to sham-ischemia 24 h after reperfusion. These observations are 436 
consistent with the concept that oxygen utilization for sodium reabsorption becomes less 437 
efficient in AKI. In support of this concept, Redfors and colleagues studied renal oxygen 438 
utilization in patients with AKI subsequent to cardiothoracic surgery (35). They found a 439 
deficit in sodium reabsorption of 59% in patients with AKI after cardiothoracic surgery 440 
compared to patients without AKI (35). In contrast, renal VO2 was similar in the two groups 441 
of patients. Furthermore, renal VO2 per unit of reabsorbed sodium was 2.4 times greater in 442 
patients with AKI than in those without AKI (35). The inefficiency of oxygen utilization for 443 
sodium reabsorption in AKI appears to be driven by multiple factors, including loss of 444 
polarity of Na
+
-K
+
-ATPase pumps, oxidative stress and reduced bioavailability of nitric oxide 445 
(17, 24). 446 
Renal tissue PO2 is determined by the balance between local DO2 and VO2 (12). 447 
Thus, tissue PO2 during recovery from AKI is likely to be model-dependent. In a model of 448 
severe AKI such as the one used in the current study, in which the filtered load of sodium 449 
(and thus oxygen utilization for sodium reabsorption) is greatly reduced but renal blood flow 450 
(and thus presumably local tissue DO2) is well preserved, the absence of tissue hypoxia, and 451 
even tissue hyperoxia, might be expected. On the other hand, tissue hypoxia might be 452 
predicted in a model of less severe renal dysfunction, and thus better preserved GFR. This 453 
concept is consistent with clinical observations in patients after renal transplantation. Using 454 
blood oxygen level-dependent magnetic resonance imaging (BOLD-MRI), Sadowski and 455 
colleagues observed greater renal medullary oxygenation in patients with acute allograft 456 
rejection than in patients with normal functioning allografts, despite the former having a 457 
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deficit in renal medullary perfusion (38). Similarly, Rosenberger and colleagues observed low 458 
HIF-1α abundance in biopsies of patients with non-functional allografts, but induction of HIF-459 
1α in biopsies from functional grafts (36). Thus, there is a strong rationale for the methods 460 
used in the current study to be applied to a less severe model of AKI, in which tissue hypoxia 461 
might be more likely to occur.  462 
It is noteworthy that HIF-1α and HIF-2α protein expression was downregulated not 463 
just at 24 h after reperfusion, presumably driven in part by increased tissue oxygen 464 
availability, but also 5 days after reperfusion, when tissue PO2 was similar in rats exposed to 465 
ischemia and sham-ischemia. Inhibition of HIF-1α and HIF-2α abundance appears to be 466 
mediated by post-translational processes at both 24 h and 5 days after reperfusion, since the 467 
expression of mRNA for these proteins was relatively normal at both time-points. The 468 
bioavailability of HIFs is influenced by various factors, such as their phosphorylation (20), 469 
and hydroxylation of proline and asparagine residues on HIFs (44) that target these protein for 470 
ubiquitinylation. The levels of proline hydroxylases (PHDs) have been shown to be unaltered 471 
following ischemia and reperfusion of the kidney (13, 39). A caveat to that is the post-472 
translational modification of HIFs by PHDs in the kidney is likely complex given that the 473 
expression patterns, and thus sensitivity, of PHDs varies in different regions of the kidney 474 
likely because of the heterogeneity of renal tissue PO2 under physiological conditions (39). It 475 
is also noteworthy that mRNA for VEGF-α and  HO-1, genes under the control of the HIF-1α 476 
and HIF-2α promoter, were not downregulated at 24 h or 5 days after reperfusion. This 477 
observation is consistent with the concept that factors other than HIFs regulate expression of 478 
these genes in the subacute phase of severe IRI. The signaling pathway for VEGFs is complex 479 
and is critical for neo-vascularization. A myriad of factors apart from HIFs, such as VEGF 480 
receptor signaling complexes and neurolipin, are able to modulate the abundance and activity 481 
of VEGFs (21). Kanellis and colleagues showed that expression of VEGF was unaltered in 482 
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response to ischemia reperfusion of the kidney (18). Interestingly, the expression of VEGF 483 
receptor 2 was increased following ischemia and VEGF was redistributed to the basolateral 484 
membrane, consistent with the established role of VEGF in the maintenance of an adequate 485 
blood supply, in remaining viable tissues, as evinced in the current study by relatively well 486 
maintained renal blood flow (19). Nevertheless, the permanent loss of peritubular capillaries, 487 
due to inadequate vascular reparation and/or neo-vascularization, appears to be an important 488 
event in the progression from ischemia-induced AKI to CKD (2, 4). 489 
Perspectives & Significance 490 
In models of AKI induced by complete renal ischemia, hypoxia during the period of 491 
ischemia is obligatory and is likely one of the drivers of necrosis and apoptosis associated 492 
with the development of AKI after reperfusion. Furthermore, other important factors during 493 
reperfusion, such as oxidative stress (5, 7) and influx of immune-modulatory cells (14, 42) are 494 
initiated, at least partly, by the hypoxia during ischemia. In the first few hours after 495 
reperfusion (acute phase), reduced renal tissue or microvascular PO2 has been observed in 496 
some (27, 28) but not all (1) cases. To the best of our knowledge, our current report describes 497 
the first detailed investigation of tissue oxygenation during the subacute phase of renal IRI. 498 
We provide compelling evidence that, at least in severe IRI modeling subacute and end stage 499 
renal disease, renal tissue hypoxia is not present 24 h and 5 days after reperfusion. It is 500 
possible that the absence of hypoxia at these time-points in this experimental model of severe 501 
IRI is a consequence of the degree of renal damage and the consequent deficit in renal oxygen 502 
consumption. Thus, future studies should focus on less severe models of AKI and follow 503 
animals for longer periods after reperfusion, to better characterize the natural history of renal 504 
oxygenation during progression from AKI to CKD.   505 
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Table 1: Systemic and blood oxygen parameters of rats 24 h or 5 days after ischemia or sham-ischemia 639 
  Sham, 24 h Ischemia, 24 h Sham, 5 days Ischemia, 5 days 2-way ANOVA 
Dichotomous 
comparison 
Parameter   N   N   N   N PTr PT PTr*T S1 Vs I1 S5 Vs I5 
Systemic 
             Body weight after 
ischemia or sham-
ischemia (g) 
397.6 ± 23.8 10 378.2 ± 17.6 9 469.4 ± 14.9 7 364.5 ± 19.7 8 0.005 0.17 0.05 0.77 0.002 
Kidney weight (g) 1.5 (1.3, 1.5) 10 1.5 (1.4, 1.6) 9 1.4 (1.4, 1.7) 7 2.2 (2.2, 2.8) 8 < 0.001 <0.001 0.04 0.92 < 0.001 
Kidney weight (g/g BW) 3.6 (3.3, 4.1) 10 3.9 (3.7, 4.2) 9 3.3 (3.2, 3.5) 7 6.6 (5.4, 8.3) 8 < 0.001 0.16 < 0.001 0.55 0.002 
Mean arterial blood 
pressure (mmHg) 
118.3 (108.4, 140.4) 10 123.9 (108.7, 134.4) 9 116.9 (102.3, 118.7) 7 116.3 (87.2, 122.3) 8 0.59 0.07 0.79 0.86 0.93 
Blood oximetry  
            Arterial blood PO2 
(mmHg) 
113.7 ± 6.1 10 89.2 ± 4.7 9 97.4 ± 5.0 7 100.7 ± 7.7 8 0.09 0.70 0.03 0.01 0.93 
Hematocrit (%) 44.8 (41.9, 45.6) 10 38.5 (35.4, 40.3) 9 43.0 (41, 44.5) 7 42.1 (41.4, 43.3) 8 0.01 0.35 0.06 0.04 0.07 
Arterial blood SO2 (%) 98.3 (97.1, 99.0) 10 96.5 (92.3, 97.5) 9 96.5 (94, 97.5) 7 97.5 (96.6, 98.5) 8 0.36 0.80 0.003 0.02 0.22 
Renal oxygen delivery 
(μmol/min) 
30.5 ± 2.7 10 21.7 ± 2.4 9 29.7 ± 5.5  7 20.8 ± 2.9 8 0.03 0.95 0.99 0.06 0.28 
Renal oxygen delivery 
(nmol/min/g BW) 
80.5 ± 2.7 10 57.7 ± 5.6 9 64.3 ± 12.7 7 56.5 ± 6.8 8 0.20 0.60 0.60 0.10 0.82 
Renal oxygen 
consumption (μmol/min) 
2.9 (1.1, 6.0) 6 1.1 (0.7, 2.7) 7 2.6 (1.8, 4.1) 7 1.4 (0.9, 2.1) 8 0.04 0.99 0.99 0.30 0.06 
Renal oxygen 
consumption 
(nmol/min/g BW) 
8.3 ± 2.8 6 4.1 ± 1.1 7 6.1 ± 1.2 7 3.8 ± 0.6 8 0.08 0.70 0.80 0.30 0.20 
Fractional extraction O2 
(%) 
10.1 (6.0, 17.8) 6 5.1 (3.3, 11.7) 7 7.9 (7.1, 14.4) 7 6.9 (4.7, 8.2) 8 0.11 0.95 0.70 0.44 0.51 
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Normality of the data was assessed using the Shapiro-Wilk test. Data that did not violate normality are expressed as mean ± standard error of the mean while data 
that violated normality are expressed as median (25th percentile, 75th percentile). PTr, PT and PTr*T are the outcomes of 2 way analysis of variance (ANOVA) with 
factors treatment (Tr) and time (T) for data that did not violate normality. For data that violated normality, an ANOVA on ranking was performed instead. 
Dichotomous comparisons of continuous variables were made using Student’s t-test for data that did not violate normality. For data that violated normality, a Mann-
Whitney U-test was performed for dichotomous comparisons. P-values for dichotomous comparisons were conservatively adjusted using the Dunn-Sidak correction 
with k=2 to account for the fact that comparisons were made at 24 h and 5 days. BW: body weight, S1: 24 h after sham-ischemia, I1: 24 h after ischemia and 
reperfusion, S5: 5 days after sham-ischemia, I5: 5 days after ischemia and reperfusion.   
 640 
Table 2: Renal hemodynamic of rats 24 h or 5 days after ischemia or sham-ischemia 641 
 642 
  Sham, 24 h Ischemia, 24 h Sham, 5 days Ischemia, 5 days 2-way ANOVA 
Dichotomous 
comparison 
Parameter   N   N   N   N PTr PT PTr*T S1 Vs I1 S5 Vs I5 
Renal blood flow (ml/min) 3.5 ± 2.9 10 3.0 ± 0.4 9 3.6 ± 0.7 7 2.4 ± 0.3 8 0.13 0.83 0.68 0.55 0.29 
Renal blood flow (μl/min/g 
BW) 
9.09 ± 0.98 10 7.93 ± 0.79 9 7.71 ± 1.59 7 6.65 ± 0.78 8 0.30 0.21 0.96 0.60 0.81 
Renal plasma flow 
(ml/min) 
1.7 (1.5, 2.1) 10 1.7 (1.4, 2.0) 9 1.6 (1.5, 3.0) 7 1.6 (0.9, 1.9) 8 0.42 0.65 0.87 0.36 0.51 
Renal plasma flow 
(μl/min/g BW) 
5.1 ± 0.6 10 4.9 ± 0.5 9 4.4 ± 0.9 7 3.8 ± 0.4 8 0.77 0.31 0.94 0.96 0.80 
Glomerular filtration rate 
(ml/min) 
0.8 (0.7, 1.2) 10 0.001 (0, 0.008) 9 1.0 (0.5, 1.8) 7 0.07 (0.01, 0.4) 9 < 0.001 0.17 0.11 < 0.001 0.14 
Glomerular filtration rate 
(nl/min/g BW) 
2400 (1520, 2960) 10 3.3 (0, 2.2) 9 2110 (1040, 3470) 7 190 (27, 1080) 8 < 0.001 0.18 0.03 < 0.001 0.20 
Urine flow (μl/min) 7.0 ± 1.0 10 1.0 ± 0.5 9 10.0 ± 4.0 7 6.0 ± 2.0 8 0.01 0.09 0.99 0.001 0.36 
Urine flow (nl/min/g BW) 16.0 (10.0, 28.0)  10 2.2 (0, 5.5) 9 17.0 (13.0, 25.0) 7 15 (1.1, 39.0) 8 0.04 0.05 0.06 0.002 0.66 
Sodium excretion 
(µmol/min) 
0.4 (0.2, 1.0) 9 0 (0, 0.18) 9 0.20 (0.2, 0.6) 7 0.20 (0.1, 0.3) 8 0.004 0.46 0.09 0.003 0.38 
Sodium excretion 
(nmol/min/g BW) 
1.0 (0.5, 2.1) 9 0 (0, 0.47) 9 0.5 (0.36, 1.3) 7 0.6 (0.35, 0.71) 8 0.02 0.53 0.05 0.01 0.90 
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Sodium reabsorption 
(µmol/min) 
111.9 (93.6, 170.2) 9 0.17 (0, 1.0) 9 138.3 (63.3, 250.4) 7 8.75 (1.5, 52.0) 8 < 0.001 0.2 0.15 < 0.001 0.14 
Sodium reabsorption 
(nmol/min/g BW) 
307.5 (204.7, 427.6) 9 0.46 (0, 2.7) 9 310 (143.6, 479.3) 7 25.7 (3.6, 153.1) 8 < 0.001 0.18 0.03 < 0.001 0.20 
Filtration fraction (%) 46.9 (34.1, 69.8) 10 0.1 (0, 0.5) 9 48.5 (29.7, 60.5) 7 7.0 (0.6, 21.7) 8 < 0.001 0.13 0.02 < 0.001 0.20 
 
             Normality of the data was assessed using the Shapiro-Wilk test. Data that did not violate normality are expressed as mean ± standard error of the mean while 
data that violated normality are expressed as median (25th percentile, 75th percentile). PTr, PT and PTr*T are the outcomes of 2 way analysis of variance 
(ANOVA) with factors treatment (Tr) and time (T) for data that did not violate normality. For data that violated normality, an ANOVA on ranking was 
performed instead. Dichotomous comparisons of continuous variables were made using Student’s t-test for data that did not violate normality. For data that 
violated normality, a Mann-Whitney U-test was performed for dichotomous comparisons. P-values for dichotomous comparisons were conservatively 
adjusted using the Dunn-Sidak correction with k=2 to account for the fact that comparisons were made at 24 h and 5 days. BW: body weight, S1: 24 h after 
sham-ischemia, I1: 24 h after ischemia and reperfusion, S5: 5 days after sham-ischemia, I5: 5 days after ischemia and reperfusion.   
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Figure 1: Temporal changes of inner medullary tissue PO2 following renal ischemia or 643 
sham ischemia. Values are mean ± SEM for rats subjected to either an hour of sham (n=5) or 644 
bilateral renal ischemia (n=7). Tissue PO2, assessed as current through the carbon paste 645 
electrode, was recorded before (day -1) and after (days 0-5) surgery. Current was averaged 646 
over 24 h period and is expressed as a percentage of its mean value on to the day before the 647 
surgery (day -1). PTreatment, PTime and PTreatment*Time are the outcomes of a 2-way repeated 648 
measures analysis of variance with factors treatment and time. * denotes P ≤ 0.05 for specific 649 
comparisons between the two treatment groups at each time point using Student’s unpaired t-650 
test, without correction for multiple comparisons. 651 
 652 
Figure 2: Assessment of tissue PO2 by Clark electrode. The electrode was first inserted 2 653 
mm into the cortex at 6 random sites across the left kidney. In panel A, multiple 654 
measurements are shown for each rat, with the various rats represented by different symbols. 655 
Filled symbols represent rats subjected to renal ischemia (n=9 at 24 h and n=8 at 5 days) 656 
while open symbols represent rats subjected to sham ischemia (n=10 at 24 h and n=7 at 5 657 
days). Measurements of cortical tissue PO2 for each rat were averaged and are presented as 658 
the between rat mean ± SEM in (B). In panel B, PTr, PT and PTr*T are the outcomes of a 2-way 659 
analysis of variance (ANOVA) with factors treatment and time. P-values above each pair of 660 
columns and error bars show the outcomes of Student’s unpaired t-test conservatively 661 
adjusted using the Dunn-sidak correction with k = 2 to account for the fact that comparisons 662 
were made at 24 h and 5 days. A tissue PO2 profile with depth was established by advancing 663 
the electrode from the cortical surface at 1 mm increments, up to 10 mm into the left kidney 664 
either 24 h (C) or 5 days (D) following recovery from either ischemia or sham-ischemia. 665 
Symbols and error bars are the mean ± SEM for rats subjected to either an hour of sham (open 666 
circles) or bilateral renal ischemia (closed circles). In panels C and D, PD, PTr and PD*Tr are the 667 
outcomes of 2-way repeated measures ANOVA with factors depth and treatment. * denotes P 668 
≤ 0.05 and is the outcome of Student’s unpaired t-test without correction for multiple 669 
comparisons  670 
 671 
Figure 3: Pimonidazole adduct immunohistochemistry of renal sections 24 h following 672 
recovery from bilateral renal ischemia or sham-ischemia. Images are typical of the 673 
cortical, outer and inner medullary region of the 6 kidneys examined in each group.  674 
 675 
Figure 4: Pimonidazole adduct immunohistochemistry of renal sections 5 days following 676 
recovery from bilateral renal ischemia or sham surgery. Images are typical of the cortical, 677 
outer and inner medullary region of the 6 kidneys examined in each group.  678 
 679 
Figure 5: Expression of HIF proteins after bilateral renal ischemia or sham ischemia. 680 
Immunoblots for HIF-1α (A-C) and HIF-2α (D-F) of tissue extracts from the cortex, outer and 681 
inner medulla of the left kidneys of rats 24 h and 5 days following recovery from either sham-682 
ischemia (open circles) or bilateral renal ischemia (closed circles); n = 6 per group. Panel G 683 
shows a typical image of the gel following electrophoresis and panel H reflects a typical 684 
image of the nitrocellulose membrane following transfer. Values are expressed as median 685 
(25
th
 percentile, 75
th
 percentile). Paired comparisons were performed using the Mann-686 
Whitney U-test. Because paired comparisons were made at two time points, P-values were 687 
conservatively adjusted using the Dunn-Sidak method with k = 2. PTr, PT and PTr*T are the 688 
outcomes of 2 way analysis of variance on ranking with the factors treatment and time. AU: 689 
arbitrary unit, S1: 24 h after sham-ischemia, S5: 5 days after sham-ischemia, I1: 24 h after 690 
ischemia, I5: 5 days after ischemia 691 
 692 
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Figure 6: mRNA expression of HIF-1α, HIF-2α, VEGF-α and HO-1. Expression of HIF-693 
1α, HIF-2α, VEGF-α and HO-1 are presented as relative to that of control animals. Values are 694 
expressed as mean ± SEM and * denotes P < 0.05 for specific comparisons between the two 695 
treatment groups at each time point using Student’s unpaired t-test. 696 
 697 
Figure 7: Collagen deposition in kidneys of rats. The percentage areas of interstitial fibrosis 698 
relative to the areas of the cortex, outer and inner medulla are shown for rats 24 h and 5 days 699 
after recovery from either sham-ischemia or bilateral renal ischemia (IR), n = 6 per group. 700 
Values are expressed as mean ± SEM. Paired comparisons were performed using Student’s 701 
unpaired t-test (*P ≤ 0.05). Because paired comparisons were made at two time points, P-702 
values were conservatively adjusted using the Dunn-Sidak method with k = 2. PTr, PT and 703 
PTr*T are the outcomes of 2 way analysis of variance with the factors treatment (Tr) and time 704 
(T). 705 
 706 
Figure 8: Indicators of renal dysfunction. Plasma concentrations of urea (A) and creatinine 707 
(B) and the urinary albumin to creatinine ratio (C) are shown for rats 24 h and 5 days after 708 
sham-ischemia (open circles) or bilateral renal ischemia (closed circles), n = 6 per group. 709 
Values are expressed as median (25
th
 percentile, 75
th
 percentile). Paired comparisons were 710 
performed using the Mann-Whitney U-test. Because paired comparisons were made at two 711 
time points, P-values were conservatively adjusted using the Dunn-Sidak method with k = 2. 712 
PTr, PT and PTr*T are the outcomes of 2 way analysis of variance on ranking with the factors 713 
treatment (Tr) and time (T).  714 
 715 
Figure 1
Figure 2
Figure 3 
Ischemia, 
24 h 
Sham, 
24 h 
Whole kidney Cortex Outer medulla Inner medulla 
Figure 4 
Ischemia, 
5 days 
Sham, 
5 days 
Whole kidney Cortex Outer medulla Inner medulla 
(A) (D)
(B)
(C)
(E)
(F)
(G)
(H)
Figure 5
Figure 6
Figure 7
Figure 8
